{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:17:39Z","timestamp":1792581459874,"version":"4.5.0"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>Objective. Retinopathy of prematurity (ROP) is a potentially avoidable cause of blindness in children. The proportion of blindness as a result of ROP varies greatly among countries depending on their level of development, being influenced by the availability of neonatal care, neonatal outcomes, and whether effective screening and treatment programs are in place. The objective of this study was to compare characteristics of premature infants who developed severe ROP between 1996 and 2002 in highly developed countries with less developed countries.<\/jats:p>\n               <jats:p>Methods. This was an observational study. A questionnaire was completed by ophthalmologists in countries with low, moderate, and high development rankings (3 highly developed countries and from 10 less well-developed countries) who screen for ROP in which they supplied birth weights and gestational ages (GAs) of infants who were treated for threshold ROP or identified with more advanced stages of the disease. Birth weights and GAs of infants with severe ROP were measured.<\/jats:p>\n               <jats:p>Results. The mean birth weights of infants from highly developed countries ranged from 737 to 763 g compared with values ranging from 903 to 1527 g in less developed countries. Mean GAs of infants from highly developed countries ranged from 25.3 to 25.6 weeks compared with 26.3 to 33.5 weeks in less developed countries. A total of 13.0% of 1091 infants from poorly developed countries exceeded United Kingdom screening criteria; 3.6% exceeded a criteria of &amp;lt;34 weeks\u2019 GA and\/or &amp;lt;1750 g birth weight.<\/jats:p>\n               <jats:p>Conclusions. These findings suggest that larger, more mature infants are developing severe ROP in countries with low\/moderate levels of development compared with highly developed countries. ROP screening programs need to use criteria that are appropriate for their local population.<\/jats:p>","DOI":"10.1542\/peds.2004-1180","type":"journal-article","created":{"date-parts":[[2005,4,2]],"date-time":"2005-04-02T01:27:21Z","timestamp":1112405241000},"page":"e518-e525","source":"Crossref","is-referenced-by-count":528,"title":["Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs"],"prefix":"10.1542","volume":"115","author":[{"given":"Clare","family":"Gilbert","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Fielder","sequence":"additional","affiliation":[{"name":"Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Gordillo","sequence":"additional","affiliation":[{"name":"Hospital Nacional E. Rebagliati, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Quinn","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Semiglia","sequence":"additional","affiliation":[{"name":"Hospital Enrique Sotomayor, Guayaquil, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Visintin","sequence":"additional","affiliation":[{"name":"Hospital Oftalmolo\u0301gico Santa Luci\u0301a, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zin","sequence":"additional","affiliation":[{"name":"Instituto Fernandes Figueira Fiocruz, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the International NO-ROP Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"key":"2021120819271335100_R1","doi-asserted-by":"crossref","unstructured":"Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet.\u20081997;350:12\u201314","DOI":"10.1016\/S0140-6736(97)01107-0"},{"key":"2021120819271335100_R2","unstructured":"United Nations Development Programme (UNDP). Human Development Report, 2004. Oxford, United Kingdom: Oxford University Press; 2004"},{"key":"2021120819271335100_R3","doi-asserted-by":"crossref","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol.\u20082003;121:1684\u20131694","DOI":"10.1001\/archopht.121.12.1684"},{"key":"2021120819271335100_R4","doi-asserted-by":"crossref","unstructured":"Reynolds JD, Dobson V, Quinn GE, et al, CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol.\u20082002;120:1470\u20131476","DOI":"10.1001\/archopht.120.11.1470"},{"key":"2021120819271335100_R5","doi-asserted-by":"crossref","unstructured":"King M. Retrolental fibroplasia. Arch Ophthalmol.\u20081950;43:695\u2013709","DOI":"10.1001\/archopht.1950.00910010705007"},{"key":"2021120819271335100_R6","unstructured":"World Health Organization. Preventing Blindness in Children: Report of WHO\/IAPB Scientific Meeting (WHO\/PBL\/00.77). Geneva, Switzerland: World Health Organization; 2000"},{"key":"2021120819271335100_R7","unstructured":"Gilbert CE, Foster A. Childhood blindness in the context of VISION 2020\u2014the Right to Sight. Bull WHO.\u20082001;79:227\u2013232"},{"key":"2021120819271335100_R8","unstructured":"UNICEF. State of the World's Children 2003. New York, NY: UNICEF; 2003"},{"key":"2021120819271335100_R9","unstructured":"World Health Organization. Maternal Health and Safe Motherhood. Low Birth Weight: a Tabulation of Available Data. WHO\/MCH\/92.2. Geneva, Switzerland: World Health Organization; 1992"},{"key":"2021120819271335100_R10","unstructured":"O'Sullivan J, Gilbert C, Foster A. The causes of childhood blindness in South Africa. S Afr Med J.\u20081997;87:1691\u20131695"},{"key":"2021120819271335100_R11","unstructured":"Baiyeroju-Agbeja AM, Omokhodion SI. Screening for retinopathy of prematurity in Idadan. Nigerian J Ophthalmol.\u20081998;6:23\u201325"},{"key":"2021120819271335100_R12","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics.\u20082001;108:809\u2013811","DOI":"10.1542\/peds.108.3.809"},{"key":"2021120819271335100_R13","doi-asserted-by":"crossref","unstructured":"Report of a Joint Working Party of the Royal College of Ophthalmologists and British Association of Perinatal Medicine. Retinopathy of prematurity: guidelines for screening and treatment. Early Hum Dev.\u20081996;46:239\u2013258","DOI":"10.1016\/S0378-3782(96)01747-1"},{"key":"2021120819271335100_R14","doi-asserted-by":"crossref","unstructured":"Lee SK, Normand C, McMillan D, et al. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med.\u20082001;155:387\u2013395","DOI":"10.1001\/archpedi.155.3.387"},{"key":"2021120819271335100_R15","doi-asserted-by":"crossref","unstructured":"Wright K, Anderson ME, Walker E, et al. Should fewer premature infants be screened for retinopathy of prematurity in the managed care era?Pediatrics.\u20081998;102:31\u201334","DOI":"10.1542\/peds.102.1.31"},{"key":"2021120819271335100_R16","doi-asserted-by":"crossref","unstructured":"Goble RR, Jones HS, Fielder AR. Are we screening too many babies for retinopathy of prematurity?Eye.\u20081997;11:509\u2013514","DOI":"10.1038\/eye.1997.136"},{"key":"2021120819271335100_R17","unstructured":"Gopal L, Sharam T, Shanmugan MP, et al. Surgery for stage 5 retinopathy of prematurity: the learning curve and evolving technique. Ind J Ophthalmol.\u20082000;48:101\u2013106"},{"key":"2021120819271335100_R18","doi-asserted-by":"crossref","unstructured":"Trinavarat A, Atchaneeyasakul LO, Udompunturak S. Applicability of American and British criteria for screening of the retinopathy of prematurity in Thailand. Jpn J Ophthalmol.\u20082004;48:50\u201353","DOI":"10.1007\/s10384-003-0014-2"},{"key":"2021120819271335100_R19","doi-asserted-by":"crossref","unstructured":"Brennan R, Gnanaraj L, Cottrell DG. Retinopathy of prematurity in practice. 1: screening for threshold disease. Eye.\u20082003;17:183\u2013188","DOI":"10.1038\/sj.eye.6700296"},{"key":"2021120819271335100_R20","doi-asserted-by":"crossref","unstructured":"Blohme J, Bengtsson-Stigmar E, Tornqvist K. Visually impaired Swedish children. Longitudinal comparisons 1980\u20131999. Acta Ophthalmol Scand.\u20082000;78:416\u2013420","DOI":"10.1034\/j.1600-0420.2000.078004416.x"},{"key":"2021120819271335100_R21","doi-asserted-by":"crossref","unstructured":"Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats D. Childhood blindness. J AAPOS.\u20081999;3:26\u201332","DOI":"10.1016\/S1091-8531(99)70091-1"},{"key":"2021120819271335100_R22","doi-asserted-by":"crossref","unstructured":"Goggin M, O'Keefe M. Childhood blindness in the Republic of Ireland: a national survey. Br J Ophthalmol.\u20081991;75:425\u2013429","DOI":"10.1136\/bjo.75.7.425"},{"key":"2021120819271335100_R23","doi-asserted-by":"crossref","unstructured":"Rosenberg T, Flage T, Hansen E, Rudanko S-L, Viggosson G, Risse R. Visual impairment in Nordic children. II. Aetiological factors. Acta Ophthalmol.\u20081992;70:155\u2013164","DOI":"10.1111\/j.1755-3768.1992.tb04119.x"},{"key":"2021120819271335100_R24","doi-asserted-by":"crossref","unstructured":"Rahi JS, Cable N; British Childhood Visual Impairment Study Group. Severe visual impairment and blindness in children in the UK. Lancet.\u20082003;362:359\u2013365","DOI":"10.1016\/S0140-6736(03)14631-4"},{"key":"2021120819271335100_R25","doi-asserted-by":"crossref","unstructured":"Kocur I, Kuchynka P, Rodny S, Barakova D, Schwartz E. Causes of severe visual impairment and blindness in children attending schools for the visually handicapped in the Czech Republic Br. J Ophthalmol.\u20082001;85:1149\u20131152","DOI":"10.1136\/bjo.85.10.1149"},{"key":"2021120819271335100_R26","unstructured":"Arrazola M. Retinopathy of Prematurity in Argentina. Master's Thesis. London, United Kingdom: International Centre for Eye Health, Institute of Ophthalmology; 1997"},{"key":"2021120819271335100_R27","unstructured":"Czeizel A, Torzs E, Diaz LG, Kovacs J, Szabo G, Vitez M. An aetiological study on 6 to 14 years old children with severe visual handicap in Hungary. Acta Pediatr Hung.\u20081991;31:365\u2013377"},{"key":"2021120819271335100_R28","doi-asserted-by":"crossref","unstructured":"Gilbert CE, Canovas R, Kocksch R, Foster A. Causes of blindness and severe visual impairment in children in Chile. Dev Med Child Neurol.\u20081994;36:326\u2013334","DOI":"10.1111\/j.1469-8749.1994.tb11853.x"},{"key":"2021120819271335100_R29","unstructured":"Reddy SC, Tan BC. Causes of childhood blindness in Malaysia: results from a national study of blind school students. Int Ophthalmol.\u20082001;24:53\u201359"},{"key":"2021120819271335100_R30","doi-asserted-by":"crossref","unstructured":"Hornby SJ, Xiao Y, Gilbert CE, et al. The causes of childhood blindness in the People's Republic of China: results from 1131 blind school students in 18 Provinces. Br J Ophthalmol.\u20081999;83:929\u2013932","DOI":"10.1136\/bjo.83.8.929"},{"key":"2021120819271335100_R31","doi-asserted-by":"crossref","unstructured":"Eckstein MB, Foster A, Gilbert C. Causes of childhood blindness in Sri Lanka. Br J Ophthalmol.\u20081995;79:633\u2013636","DOI":"10.1136\/bjo.79.7.633"},{"key":"2021120819271335100_R32","doi-asserted-by":"crossref","unstructured":"Rogers NK, Gilbert CE, Zakhidov BO, McCollum CJ, Foster A. Childhood blindness in Uzbekistan. Eye.\u20081999;13:65\u201370","DOI":"10.1038\/eye.1999.13"},{"key":"2021120819271335100_R33","doi-asserted-by":"crossref","unstructured":"Bulgan T, Gilbert C. Prevalence and causes of severe visual impairment and blindness in children in Mongolia. Ophthalmol Epidemiol.\u20082002;9:271\u2013281","DOI":"10.1076\/opep.9.4.271.1512"},{"key":"2021120819271335100_R34","unstructured":"Hornby SJ, Adolph S, Gothwal VK, Gilbert CE, Dandona L, Foster A. Evaluation of children in six schools for the blind in Andhra Pradesh. Ind J Ophthalmol.\u20082000;48:195\u2013200"},{"key":"2021120819271335100_R35","doi-asserted-by":"crossref","unstructured":"Rahi J, Sripathi S, Gilbert CE, Foster A. Childhood blindness in India: causes in 1,318 blind school students in 9 states. Eye.\u20081995;9:545\u2013550","DOI":"10.1038\/eye.1995.137"},{"key":"2021120819271335100_R36","doi-asserted-by":"crossref","unstructured":"Jeewan ST, Pal N, Murthy GVS, et al. Causes and temporal trends of blindness and severe visual impairment in children in schools for the blind in North India. Br J Ophthalmol.\u20082003;87:941\u2013945","DOI":"10.1136\/bjo.87.8.941"},{"key":"2021120819271335100_R37","doi-asserted-by":"crossref","unstructured":"Kello AB, Gilbert CE. Causes of severe visual impairment and blindness in children in schools for the blind in Ethiopia. Br J Ophthalmol.\u20082003;87:526\u2013530","DOI":"10.1136\/bjo.87.5.526"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/e518\/1028723\/zpe0050500e518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/e518\/1028723\/zpe0050500e518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:50:51Z","timestamp":1638996651000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/5\/e518\/67566\/Characteristics-of-Infants-With-Severe-Retinopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1180","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}